Nuveen Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 89,566 shares of COLL stock, worth $3.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,566

Previous 88,770 0.9%

Holding current value

$3.43 Million

Previous $3.45 Million 16.31%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$31.36 - $39.99 $24,962 - $31,832	796 Added 0.9%	89,566 $2.88 Million
Q1 2024 May 13, 2024	SELL	$31.23 - $40.91 $111,147 - $145,598	-3,559 Reduced 3.85%	88,770 $3.45 Million
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $19,509 - $28,397	922 Added 1.01%	92,329 $2.84 Million
Q3 2023 Nov 14, 2023	SELL	$21.23 - $24.28 $27,599 - $31,564	-1,300 Reduced 1.4%	91,407 $2.04 Million
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $1.64 Million - $1.87 Million	-77,833 Reduced 45.64%	92,707 $1.99 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $2.02 Million - $2.63 Million	-87,869 Reduced 34.0%	170,540 $4.09 Million
Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $147,535 - $215,270	9,141 Added 3.67%	258,409 $6 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $42,994 - $55,898	-2,781 Reduced 1.1%	249,268 $3.99 Million
Q2 2022 Aug 15, 2022	BUY	$14.22 - $20.88 $30,558 - $44,871	2,149 Added 0.86%	252,049 $4.47 Million
Q1 2022 May 16, 2022	SELL	$17.2 - $22.5 $13,244 - $17,325	-770 Reduced 0.31%	249,900 $4.81 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $150,745 - $183,908	-8,614 Reduced 3.32%	250,670 $4.68 Million
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $611,097 - $874,126	-34,428 Reduced 11.72%	259,284 $5.12 Million
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $571,001 - $663,979	26,265 Added 9.82%	293,712 $6.94 Million
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $15,765 - $21,375	-819 Reduced 0.31%	267,447 $6.34 Million
Q4 2020 May 17, 2021	SELL	$17.83 - $22.29 $324,577 - $405,767	-18,204 Reduced 6.35%	268,266 $5.37 Million
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $107,568 - $134,475	6,033 Added 2.15%	286,470 $5.74 Million
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $128,133 - $169,058	-8,120 Reduced 2.81%	280,437 $5.84 Million
Q2 2020 Aug 14, 2020	BUY	$15.49 - $23.51 $178,274 - $270,576	11,509 Added 4.15%	288,557 $5.05 Million
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $190,959 - $349,886	13,748 Added 5.22%	277,048 $4.52 Million
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $251,182 - $522,083	23,475 Added 9.79%	263,300 $5.42 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $411,134 - $537,388	40,466 Added 20.3%	239,825 $2.75 Million
Q2 2019 Aug 15, 2019	BUY	$10.62 - $16.59 $2.12 Million - $3.31 Million	199,359 New	199,359 $2.62 Million

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.31B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History